Influx Healthtech Complete Financial Statements

In FYNone, Influx Healthtech (INFLUX) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 12.4% and ROE of 36.1%. Full financial statements from FY2021 to FY2025 (5 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see INFLUX stock price BSE.

5 Years of Data
2025 - 2021

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 12.38% 2025 data
EBITDA Margin 20.00% 2025 data
Operating Margin 20.00% 2025 data
Return on Assets 18.57% 2025 data
Return on Equity 36.11% 2025 data

Balance Sheet Ratios

Equity Ratio 51.43% 2025 data
Asset Turnover 1.50 2025 data

INFLUX Revenue, Net Profit & EBITDA — Year-on-Year Growth

INFLUX YoY (March 2025 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%.

Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+70.7%
Year-over-Year
Equity Growth
+56.5%
Year-over-Year
Operating Cash Flow Growth
-22.2%
Year-over-Year
Investing Cash Flow Growth
-12.5%
Year-over-Year
Financing Cash Flow Growth
+100.0%
Year-over-Year

INFLUX Income Statement — Revenue, EBITDA & Net Profit

Influx Healthtech revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 12.4%. Explore INFLUX Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021
Revenue 0 105 100 76 59 0
Expenses 0 84 83 65 53 0
EBITDA 0 21 17 11 6 0
Operating Profit Margin % 0.00% 20.00% 17.00% 14.00% 11.00% 0.00%
Depreciation 0 3 2 1 0 0
Interest 0 0 0 0 0 0
Profit Before Tax 0 18 15 10 6 0
Tax 0 5 4 3 2 0
Net Profit 0 13 11 7 5 0
Earnings Per Share (₹) 0.00 7.36 6.13 3.96 1801.90 -1.75

INFLUX Balance Sheet — Assets, Liabilities & Shareholders' Equity

INFLUX total assets ₹70 Cr, total equity ₹36 Cr, total liabilities ₹ Cr (2025) — ROE 36.1%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021
ASSETS
Total Assets 70 41 28 18 0
Current Assets 49 26 20 14 0
Fixed Assets 19 14 6 3 0
Capital Work in Progress 0 0 0 0 0
Investments 0 0 0 0 0
Other Assets 52 27 22 15 0
LIABILITIES
Total Liabilities
Current Liabilities 0 0 0 1 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 36 23 12 5 0
Share Capital 18 0 0 0 0
Reserves & Surplus 18 23 12 5 0

INFLUX Cash Flow Statement — Operating, Investing & Financing

Influx Healthtech operating cash flow ₹7 Cr, investing ₹-9 Cr, financing ₹0 Cr, net cash flow ₹-2 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021
Operating Activities 7 9 7 4 0
Investing Activities -9 -8 -5 -3 0
Financing Activities 0 -1 0 1 0
Net Cash Flow -2 0 2 1 0